ArticlePLoS neglected tropical diseases2022
Estimating chikungunya virus transmission parameters and vector control effectiveness highlights key factors to mitigate arboviral disease outbreaks.
Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Surveillance and control efficacy of the Bergerac, France, 2025 chikungunya outbreak.PLoS neglected tropical diseases · 2026Article
- Epidemiology, transmission, vector and factors analysis of chikungunya outbreak in 2025, Quanzhou City of China.Frontiers in public health · 2026Article
- Lessons from an investigation of an autochthonous chikungunya outbreak in Bergerac, mainland France, June to October 2025.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
- Modeling Outbreak Prediction and the Impact of Emergency Vaccination on the 2024-2025 Chikungunya Outbreak in La Réunion.Vaccines · 2025Article
- Effects of Temperature Dependence in Mosquito Mortality on Simulated Chikungunya Virus Transmission.Viruses · 2025Article
- Estimating the transmissibility of the 2025 chikungunya fever outbreak in Foshan, China: a modelling study.Infectious diseases of poverty · 2025Article
- Modeling platform to assess the effectiveness of single and integrated Ixodes scapularis tick control methods.Parasites & vectors · 2024Article
- Reporting delays of chikungunya cases during the 2017 outbreak in Lazio region, Italy.PLoS neglected tropical diseases · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundViruses transmitted by Aedes mosquitoes have greatly expanded their geographic range in recent decades. They are considered emerging public health threats throughout the world, including Europe. Therefore, public health authorities must be prepared by quantifying the potential magnitude of virus transmission and the effectiveness of interventions. METHODOLOGY: We developed a mathematical model with a vector-host structure for chikungunya virus transmission and estimated model parameters from epidemiological data of the two main autochthonous chikungunya virus transmission events that occurred in Southern France, in Montpellier (2014) and in Le Cannet-des-Maures (2017). We then performed simulations of the model using these estimates to forecast the magnitude of the foci of transmission as a function of the response delay and the moment of virus introduction.
conclusionsThe results of the different simulations underline the relative importance of each variable and can be useful to stakeholders when designing context-based intervention strategies. The findings emphasize the importance of, and advocate for early detection of imported cases and timely biological confirmation of autochthonous cases to ensure timely vector control measures, supporting the implementation and the maintenance of sustainable surveillance systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.